Search Results - "WOLNER, E."

Early failure of the tissue engineered porcine heart valve SYNERGRAFT® in pediatric patients by Simon, P., Kasimir, M.T., Seebacher, G., Weigel, G., Ullrich, R., Salzer-Muhar, U., Rieder, E., Wolner, E.

“…Objectives: The first tissue engineered decellularized porcine heart valve, Synergraft® (Cryolife Inc., USA) was introduced in Europe as an alternative to…”
Get full text

Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery by Z. Konakci, K., Bohle, B., Blumer, R., Hoetzenecker, W., Roth, G., Moser, B., Boltz-Nitulescu, G., Gorlitzer, M., Klepetko, W., Wolner, E., Ankersmit, H. J.

“…Background  The α‐Gal (Galα1,3‐Galβ1–4GlcNAc‐R) epitope is the major xenoantigen causing hyperacute rejection of pig organs transplanted into primates. Porcine…”
Get full text

Development of Proteinuria After Switch to Sirolimus‐Based Immunosuppression in Long‐Term Cardiac Transplant Patients by Aliabadi, A. Z., Pohanka, E., Seebacher, G., Dunkler, D., Kammerstätter, D., Wolner, E., Grimm, M., Zuckermann, A. O.

“…Calcineurin‐inhibitor therapy can lead to renal dysfunction in heart transplantation patients. The novel immunosuppressive (IS) drug sirolmus (Srl) lacks…”
Get full text

Comparison of different decellularization procedures of porcine heart valves by Kasimir, M T, Rieder, E, Seebacher, G, Silberhumer, G, Wolner, E, Weigel, G, Simon, P

“…Tissue engineering of heart valves should avoid the disadvantages of conventional prostheses. In this study we tested different decellularization procedures…”
Get full text

Heightened levels of circulating 20S proteasome in critically ill patients by Roth, G. A., Moser, B., Krenn, C., Roth-Walter, F., Hetz, H., Richter, S., Brunner, M., Jensen-Jarolim, E., Wolner, E., Hoetzenecker, K., Boltz-Nitulescu, G., Ankersmit, H. J.

“…Background  Recently, circulating proteasome core particles (20S proteasome) have been suggested as a marker of cell damage and immunological activity in…”
Get full text

Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers by Groeger, A M, Esposito, V, De Luca, A, Cassandro, R, Tonini, G, Ambrogi, V, Baldi, F, Goldfarb, R, Mineo, T C, Baldi, A, Wolner, E

“…Aims : Some experimental evidence suggests that in lung cancer, development, progression and an increased proliferation rate can be linked to apoptosis‐related…”
Get full text

Endoluminal stent-graft placement in patients with acute aortic dissection type B by Hutschala, D., Fleck, T., Czerny, M., Ehrlich, M., Schoder, M., Lammer, J., Wolner, E., Grabenwöger, M.

“…Objectives: This study was performed to evaluate the feasibility, safety and effectiveness of endovascular stent-grafting in treating Stanford type B acute…”
Get full text

Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery by Szerafin, T, Niederpold, T, Mangold, A, Hoetzenecker, K, Hacker, S, Roth, G, Lichtenauer, M, Dworschak, M, Wolner, E, Ankersmit, H J

“…Cardiopulmonary bypass is known to affect cytokine release leading to a generalized endogenous immune reaction similar to that described in sepsis, without…”
Get more information

Donor Myocardial HIF‐1α Is an Independent Predictor of Cardiac Allograft Dysfunction: A 7‐Year Prospective, Exploratory Study by Aharinejad, S., Schäfer, R., Krenn, K., Zuckermann, A., Schneider, B., Neumann, F., Paulus, P., Wieselthaler, G., Wolner, E., Grimm, M.

“…Knowledge on interplay between the cardiac molecular response to transplantation‐induced stress and primary graft dysfunction (PGD) is limited. A cDNA array…”
Get full text

Mid-term Results of Conservative, Conventional and Endovascular Treatment for Acute Traumatic Aortic Lesions by Stampfl, P., Greitbauer, M., Zimpfer, D., Fleck, T., Schoder, M., Lammer, J., Wolner, E., Grimm, M., Vécsei, V., Czerny, M.

“…To analyze our results after conservative, conventional and endovascular treatment for acute traumatic aortic lesions during the last decade. From June 1993 to…”
Get full text

Analysis of cell cycle regulator proteins in non-small cell lung cancer by Esposito, V, Baldi, A, Tonini, G, Vincenzi, B, Santini, M, Ambrogi, V, Mineo, T C, Persichetti, P, Liuzzi, G, Montesarchio, V, Wolner, E, Baldi, F, Groeger, A M

“…Background/Aims: Abnormalities of the proteins involved in cell cycle checkpoints are extremely common among almost all neoplasms. This study aimed to…”
Get full text

The impact of diabetes mellitus at the time of heart transplantation on long-term survival by CZERNY, M, SAHIN, V, FASCHING, P, ZUCKERMANN, A, ZIMPFER, D, KILO, J, WOLNER, E, GRIMM, M

“…To analyse the impact of diabetes mellitus (DM) at the time of heart transplantation on long-term survival and incidence of transplant coronary artery disease…”
Get full text

Elevated levels of interleukin-1β-converting enzyme and caspase-cleaved cytokeratin-18 in acute myocardial infarction by Adlbrecht, C., Hoetzenecker, K., Posch, M., Steiner, S., Kopp, C., Hacker, S., Auer, J., Horvath, R., Moser, B., Roth, G., Wolner, E., Lang, I. M., Ankersmit, H. J.

“…Background  Systemic inflammation and apoptosis‐specific immune activation play a major role in acute coronary syndromes (ACS) including acute myocardial…”
Get full text

Results of open heart surgery in Jehovah's Witnesses patients by Juraszek, A, Dziodzio, T, Roedler, S, Kral, A, Hutschala, D, Wolner, E, Grimm, M, Czerny, M

“…The aim of this paper was to evaluate the results in patients from the religious community of Jehovah's Witnesses (JW) undergoing open heart surgery. Between…”
Get full text

495: You Are What You Eat or the Fatter the Better? Obesity as Risk Factor in Cardiac Transplant Receipients by Mahr, S.L, Dunkler, D, Groemmer, M, Aliabadi, A, Zimpfer, D, Grimm, M, Wolner, E, Zuckermann, A.O

Get full text

572: Post-Transplant Outcome of Elective vs. LVAD vs. Urgent Patients Undergoing Cardiac Transplantation by Zimpfer, D, Mahr, S, Aliabadi, A, Groemmer, M, Dunkler, D, Sandner, S, Wieselthaler, G, Wolner, E, Grimm, M, Zuckermann, A

Get full text

74: Incidence and Outcome of De-Novo Malignancy after Cardiac Transplantation – 20 Years Experience of a Single Center by Mahr, S.L, Paireder, M.E, Aliabadi, A.Z, Seebacher, G, Grimm, M, Wolner, E, Zuckermann, A.O

Get full text

249: Anemia Is a Risk Factor for Survival after Cardiac Transplantation by Aliabadi, A.Z, Dunkler, D, Seebacher, G, Roedler, S, Wolner, E, Grimm, M, Zuckermann, A.O

Get full text

Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump by Ankersmit, H.J., Wieselthaler, G., Moser, B., Gerlitz, S., Roth, G., Boltz-Nitulescu, G., Wolner, E.

“…Background: The development of local and systemic infection is a significant risk factor associated with implantation of a ventricular assist device. The…”
Get full text

364: ECMO as Support of Primary Graft Dysfunction (PGD) in Cardiac Transplantation by Groemmer, M, Mahr, S, Aliabadi, A.Z, Grimm, M, Zuckermann, A.O, Wieselthaler, G, Wolner, E, Rajek, A.M, Herbert, K, Barbara, S, Taghavi, S

Get full text